David Canton

Upon completion of his post-doctoral studies, Dr. Canton joined OncoSec as a Scientist in 2014. Over the past 8 years, he has held leadership positions overseeing plasmid molecular design, immune monitoring and biomarker development, and OncoSec’s Discovery platform.

Dr. Canton received his Ph.D. in Biochemistry from Western University (Ontario Canada) and did his post-doctoral research at an HHMI laboratory. He holds bachelor’s degrees in Science (Biochemistry) and Art (Music) from Bishop’s University.